Black Garlic Nutraceuticals and Blood Pressure Control
- Conditions
- Hypertension
- Interventions
- Dietary Supplement: ABG+ Black GarlinDietary Supplement: Crystalline Cellulose
- Registration Number
- NCT04915053
- Lead Sponsor
- Universitat de Lleida
- Brief Summary
Black garlic contains a series of allyl-sulfur compounds with the ability to modulate nitric oxide synthetase, angiotensin-converting enzyme system, and endothelial activation, which together could help better control blood pressure. The main objective of this study is to evaluate the effect on blood pressure and endothelial health of a daily intake of a black garlic supplement named ABG (registered mark), which has a higher concentration of black garlic bioactive compounds, in people with moderate hypertension.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
- Clinical hypertension, medically treated with no more than 2 drugs
- Body mass index above 35 kg/m2
- Fasting blood cholesterol levels below 115 mg/dL
- Fasting blood glucose levels above 126 mg/dL
- Taking anyone of the Angiotensin-converting enzyme inhibitors
- Anemia (hemoglobin below 13 g/dL in men and below 12 g/dL in women)
- Vitamin or nutraceutical intake in the last 30 days before the study enrollment
- Chronic gastrointestinal diseases
- Pregnancy and breastfeeding
- Garlic allergy
- Participation in another study 30 days before the study enrollment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description ABG Black Garlic Extract ABG+ Black Garlin Daily intake of a 550 mg tablet, containing 250 mg of Black Garlic Extract and 300 mg of excipients. Placebo Crystalline Cellulose Daily intake of a 550 mg tablet, containing 250 mg of microcrystalline cellulose and 300 mg of excipients
- Primary Outcome Measures
Name Time Method Change in Blood Pressure Baseline and 12 weeks Indirect measure of blood pressure by a trained physician
- Secondary Outcome Measures
Name Time Method Change in Blood nitric oxide content Baseline and 12 weeks Nitric oxide determined by nitrate and nitrite content in blood
Change in Angiotensin-converting enzyme activity Baseline and 12 weeks Activity measured by a substrate-enzyme activity kit
Change in Endothelial function Baseline and 12 weeks Endothelial blood flow capacity
Change in Blood lipid profile Baseline and 12 weeks Analysis of lipid profile (Total-cholesterol, LDL-cholesterol, Triacylglycerides, HDL-Cholesterol)
Change in Blood cytokine profile Baseline and 12 weeks Analysis of cytokine profile (TNFa, IL-1b, IL-18, IL-6, IL-8, IL-17, IL-23, TGFb) in blood by immunoassays (Multiplexed)
Change in Blood antioxidant capacity Baseline and 12 weeks Reduction capacity of blood determined by a biochemistry assay
Trial Locations
- Locations (1)
Hospital Arnau de Vilanova
🇪🇸Lleida, Spain